Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1019575-98-4
2. 4-(morpholin-4-yl)benzene-1-carboximidamide
3. 4-morpholin-4-ylbenzenecarboximidamide
4. 4-morpholinobenzimidamide Hydrochloride
5. Dtxsid40651414
6. Mfcd09745458
7. Zinc19865701
8. Akos000218177
9. As-65440
10. Benzenecarboximidamide, 4-(4-morpholinyl)-
11. Cs-0268345
12. W10693
| Molecular Weight | 205.26 g/mol |
|---|---|
| Molecular Formula | C11H15N3O |
| XLogP3 | 0.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 205.121512110 g/mol |
| Monoisotopic Mass | 205.121512110 g/mol |
| Topological Polar Surface Area | 62.3 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 218 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
55
PharmaCompass offers a list of 4-Morpholinobenzimidamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 4-Morpholinobenzimidamide manufacturer or 4-Morpholinobenzimidamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 4-Morpholinobenzimidamide manufacturer or 4-Morpholinobenzimidamide supplier.
PharmaCompass also assists you with knowing the 4-Morpholinobenzimidamide API Price utilized in the formulation of products. 4-Morpholinobenzimidamide API Price is not always fixed or binding as the 4-Morpholinobenzimidamide Price is obtained through a variety of data sources. The 4-Morpholinobenzimidamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 0525AA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 0525AA, including repackagers and relabelers. The FDA regulates 0525AA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 0525AA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 0525AA supplier is an individual or a company that provides 0525AA active pharmaceutical ingredient (API) or 0525AA finished formulations upon request. The 0525AA suppliers may include 0525AA API manufacturers, exporters, distributors and traders.
0525AA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 0525AA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 0525AA GMP manufacturer or 0525AA GMP API supplier for your needs.
A 0525AA CoA (Certificate of Analysis) is a formal document that attests to 0525AA's compliance with 0525AA specifications and serves as a tool for batch-level quality control.
0525AA CoA mostly includes findings from lab analyses of a specific batch. For each 0525AA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
0525AA may be tested according to a variety of international standards, such as European Pharmacopoeia (0525AA EP), 0525AA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (0525AA USP).
